372487007: Ondansetron (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\5-HT3 receptor antagonist\Ondansetron (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\5-HT3 receptor antagonist\Ondansetron (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Tricyclic compound (substance)\Ondansetron (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ondansetron (substance)	Is a	5-HT3 receptor antagonist	true	Inferred relationship	Some
Ondansetron (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	5-HT3 receptor antagonist	true	Inferred relationship	Some
Ondansetron (substance)	Is a	Tricyclic compound (substance)	true	Inferred relationship	Some
Ondansetron (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ondansetron hydrochloride	Is a	False	Ondansetron (substance)	Inferred relationship	Some
Product containing ondansetron (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ondansetron (substance)	Inferred relationship	Some	1
ondansetron 2 mg/mL, ampoule de 2 mL de solution pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Ondansetron (as ondansetron hydrochloride) 4 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Product containing precisely ondansetron 8 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
ondansetron 2 mg/mL, ampoule de 4 mL de solution pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Ondansetron 4mg/5mL sugar free syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Product containing precisely ondansetron 16 milligram/1 each conventional release rectal suppository (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Ondansetron 4mg wafer	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Ondansetron 8mg wafer	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Ondansetron 0.64mg/mL injection solution 50mL ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Product containing ondansetron in oropharyngeal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release orodispersible film (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible film (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some
Product containing ondansetron in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron-containing product in rectal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron (as ondansetron hydrochloride) 4 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron 8 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron 8 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron 16 milligram/1 each conventional release rectal suppository (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron 16 milligram/1 each conventional release rectal suppository (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron 8 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Ondansetron (substance)	Inferred relationship	Some
Ondansetron-containing product in oromucosal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron (as ondansetron hydrochloride) 800 microgram/mL oral solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/2 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/4 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing only ondansetron in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing only ondansetron in rectal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron (as ondansetron hydrochloride) 2 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release orodispersible film (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/1 each conventional release orodispersible film (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron 4 mg oral lyophilisate	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ondansetron (substance)	Inferred relationship	Some	1
Ondansetron 4 mg oral lyophilisate	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron 8 milligram/1 each conventional release oral lyophilisate (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron 8 milligram/1 each conventional release oral lyophilisate (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1
Product containing precisely ondansetron (as ondansetron hydrochloride) 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Ondansetron (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1197780019	Ondansetron (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211022017	Ondansetron	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
50151000195111	ondansetron	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
829511000172118	ondansétron	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
64301000195110	Ondansetron	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module